8-KThe WireRoutine
Bylaw Amendment
Filed Apr 22, 2025 · 1y ago · Accession 0001193125-25-089189
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Seres Therapeutics, Inc.
- Ticker
- MCRB
- CIK
- 1609809
- Form type
- 8-K
- Filing date
- Apr 22, 2025
- Report date
- Apr 21, 2025
- Document
- d97309d8k.htm
- Size
- 162 KB